HomeCompareCVS vs FMC

CVS vs FMC: Dividend Comparison 2026

CVS yields 3.79% · FMC yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CVS wins by $54.4K in total portfolio value
10 years
CVS
CVS
● Live price
3.79%
Share price
$70.14
Annual div
$2.66
5Y div CAGR
33.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$82.5K
Annual income
$21,585.11
Full CVS calculator →
FMC
FMC
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full FMC calculator →

Portfolio growth — CVS vs FMC

📍 CVS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCVSFMC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CVS + FMC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CVS pays
FMC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVS
Annual income on $10K today (after 15% tax)
$322.36/yr
After 10yr DRIP, annual income (after tax)
$18,347.34/yr
FMC
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, CVS beats the other by $17,583.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVS + FMC for your $10,000?

CVS: 50%FMC: 50%
100% FMC50/50100% CVS
Portfolio after 10yr
$55.3K
Annual income
$11,242.15/yr
Blended yield
20.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CVS right now

CVS
Analyst Ratings
2
Strong
33
Buy
6
Hold
Consensus: Buy
Price Target
$95.15
+35.7% upside vs current
Range: $90.00 — $103.00
Altman Z
2.2
Piotroski
6/9
FMC
Analyst Ratings
20
Buy
21
Hold
1
Sell
Consensus: Hold
Price Target
$19.07
-61.9% upside vs current
Range: $13.00 — $43.00
Altman Z
1.2
Piotroski
3/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVS buys
0
FMC buys
0
No recent congressional trades found for CVS or FMC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCVSFMC
Forward yield3.79%4.00%
Annual dividend / share$2.66$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR33.8%5%
Portfolio after 10y$82.5K$28.0K
Annual income after 10y$21,585.11$899.19
Total dividends collected$55.6K$6.4K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyHold
Analyst price target$95.15$19.07

Year-by-year: CVS vs FMC ($10,000, DRIP)

YearCVS PortfolioCVS Income/yrFMC PortfolioFMC Income/yrGap
1← crossover$11,207$507.43$11,120$420.00+$87.00CVS
2$12,703$711.13$12,357$458.31+$346.00CVS
3$14,600$1,007.92$13,721$499.76+$879.00CVS
4$17,071$1,448.60$15,227$544.58+$1.8KCVS
5$20,384$2,117.95$16,885$593.02+$3.5KCVS
6$24,973$3,162.40$18,713$645.34+$6.3KCVS
7$31,566$4,844.81$20,724$701.81+$10.8KCVS
8$41,433$7,657.67$22,938$762.73+$18.5KCVS
9$56,902$12,568.96$25,372$828.41+$31.5KCVS
10$82,471$21,585.11$28,047$899.19+$54.4KCVS

CVS vs FMC: Complete Analysis 2026

CVSHealthcare

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Full CVS Calculator →

FMCMaterials

FMC is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in FMC shares.

Full FMC Calculator →
📬

Get this CVS vs FMC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVS vs SCHDCVS vs JEPICVS vs OCVS vs KOCVS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.